A study of DW1807 for year-round allergies and asthma
Treatments studied
Part of Ear, nose & throat, Immune system & allergy, Lungs & breathing clinical trials.
This trial tests a new medicine called DW1807 for people who have both year-round allergies (like dust mites or pet dander) and asthma. It aims to see if it helps control nasal symptoms and is safe to use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years or older.
- You have had year-round nasal allergies for at least 2 years.
- A skin or blood test in the past year shows you are allergic to something like dust mites, cats, or mold.
- You have asthma that is well-controlled with Step 2 to Step 4 treatments.
- Your average nasal symptom score over a week is 6 or higher out of 12.
- You have not had an asthma attack or a cold in the past few weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an under-the-tongue tablet for people with dust mite allergies causing moderate to severe nasal symptoms or mild-to-moderate asthma. The goal is to see if it improves symptoms and can replace or reduce the need for allergy medicines.
This study tests an investigational injection (called JYB1904) to see if it helps reduce allergy symptoms from dust mites, pet dander, and other indoor allergens. It is for adults with moderate to severe allergic rhinitis (hay fever) who still have symptoms despite using a daily nasal steroid spray.
This study tests a new medicine called DEP114 for children aged 6 to 12 who have severe symptoms from persistent allergic rhinitis (year-round allergies). The medicine may help reduce nasal congestion and other allergy symptoms.
This trial tests a new medicine for children with moderate to severe allergic rhinitis (a condition that causes a stuffy, runny, or itchy nose). It aims to see if the new medicine is safe and effective in reducing these symptoms compared to current treatments.
This trial tests if allergy shots (allergen-specific immunotherapy) can reduce symptoms of moderate to severe dust mite allergy. You will be in a room that exposes you to dust mites to see how well the treatment works, compared to a placebo.
This Phase 2 study tests a “viral” treatment meant to reprogram the lining of your nose to reduce allergy-like immune responses. It is testing whether this approach is safe and can help people with cat allergy (with or without asthma) or compare against healthy people.
Hear when a new Perennial Allergic Rhinitis Accompanied by Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.